(BA) The Boeing - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0970231058
Stock: Aircraft, Spacecraft, Defense Systems, Support
Total Rating 55
Risk 79
Buy Signal -0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -5.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 18.85 |
| Character TTM | |
|---|---|
| Beta | 1.213 |
| Beta Downside | 1.308 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.31% |
| CAGR/Max DD | 0.07 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 93.5668
Description: BA The Boeing March 04, 2026
Boeing designs, develops, and manufactures commercial jetliners, military aircraft, satellites, and missile defense systems. The company also provides related services.
Boeings business model is diversified across three segments: Commercial Airplanes, Defense, Space & Security, and Global Services. The aerospace and defense sector is characterized by long product development cycles and high capital expenditure requirements.
The Commercial Airplanes segment focuses on passenger and cargo aircraft. The Defense, Space & Security segment handles military aircraft, weapons systems, strategic defense, and satellite systems. The Global Services segment provides maintenance, logistics, training, and digital services to both commercial and defense clients, a common offering for original equipment manufacturers.
Further research on ValueRay can provide detailed financial analysis of these segments.
Headlines to watch out for
- Commercial aircraft delivery delays impact revenue
- Defense contract awards drive segment growth
- Global air travel demand influences order backlog
- Supply chain disruptions increase production costs
- Regulatory scrutiny affects aircraft certification timelines
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 2.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 8.09 > 1.0 |
| NWC/Revenue: 32.95% < 20% (prev 46.48%; Δ -13.53% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.06b > Net Income 2.23b |
| Net Debt (43.18b) to EBITDA (7.36b): 5.87 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (795.1m) vs 12m ago 10.72% < -2% |
| Gross Margin: 4.83% > 18% (prev -0.03%; Δ 485.7% > 0.5%) |
| Asset Turnover: 55.12% > 50% (prev 42.54%; Δ 12.58% > 0%) |
| Interest Coverage Ratio: 1.95 > 6 (EBITDA TTM 7.36b / Interest Expense TTM 2.77b) |
Altman Z'' 1.79
| A: 0.18 (Total Current Assets 137.59b - Total Current Liabilities 108.11b) / Total Assets 168.24b |
| B: 0.10 (Retained Earnings 17.25b / Total Assets 168.24b) |
| C: 0.03 (EBIT TTM 5.41b / Avg Total Assets 162.30b) |
| D: 0.07 (Book Value of Equity 12.04b / Total Liabilities 162.78b) |
| Altman-Z'' Score: 1.79 = BBB |
Beneish M -3.03
| DSRI: 0.80 (Receivables 12.08b/11.20b, Revenue 89.46b/66.52b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.84 (AQ_t 0.09 / AQ_t-1 0.11) |
| SGI: 1.34 (Revenue 89.46b / 66.52b) |
| TATA: 0.01 (NI 2.23b - CFO 1.06b) / TA 168.24b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of BA shares?
As of March 10, 2026, the stock is trading at USD 225.00 with a total of 8,398,965 shares traded.
Over the past week, the price has changed by -2.06%, over one month by -8.05%, over three months by +12.29% and over the past year by +51.87%.
Over the past week, the price has changed by -2.06%, over one month by -8.05%, over three months by +12.29% and over the past year by +51.87%.
Is BA a buy, sell or hold?
The Boeing has received a consensus analysts rating of 4.13.
Therefore, it is recommended to buy BA.
- StrongBuy: 16
- Buy: 4
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the BA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 271.6 | 20.7% |
| Analysts Target Price | 271.6 | 20.7% |
BA Fundamental Data Overview March 10, 2026
P/E Trailing = 93.5668
P/E Forward = 163.9344
P/S = 2.0288
P/B = 33.3153
P/EG = 6.5305
Revenue TTM = 89.46b USD
EBIT TTM = 5.41b USD
EBITDA TTM = 7.36b USD
Long Term Debt = 45.64b USD (from longTermDebt, last quarter)
Short Term Debt = 8.46b USD (from shortTermDebt, last quarter)
Debt = 54.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.18b USD (from netDebt column, last quarter)
Enterprise Value = 224.68b USD (181.50b + Debt 54.10b - CCE 10.92b)
Interest Coverage Ratio = 1.95 (Ebit TTM 5.41b / Interest Expense TTM 2.77b)
EV/FCF = -119.7x (Enterprise Value 224.68b / FCF TTM -1.88b)
FCF Yield = -0.84% (FCF TTM -1.88b / Enterprise Value 224.68b)
FCF Margin = -2.10% (FCF TTM -1.88b / Revenue TTM 89.46b)
Net Margin = 2.50% (Net Income TTM 2.23b / Revenue TTM 89.46b)
Gross Margin = 4.83% ((Revenue TTM 89.46b - Cost of Revenue TTM 85.14b) / Revenue TTM)
Gross Margin QoQ = 7.57% (prev -10.21%)
Tobins Q-Ratio = 1.34 (Enterprise Value 224.68b / Total Assets 168.24b)
Interest Expense / Debt = 1.22% (Interest Expense 659.0m / Debt 54.10b)
Taxrate = 1.19% (99.0m / 8.32b)
NOPAT = 5.34b (EBIT 5.41b * (1 - 1.19%))
Current Ratio = 1.27 (Total Current Assets 137.59b / Total Current Liabilities 108.11b)
Debt / Equity = 9.92 (Debt 54.10b / totalStockholderEquity, last quarter 5.45b)
Debt / EBITDA = 5.87 (Net Debt 43.18b / EBITDA 7.36b)
Debt / FCF = -23.00 (negative FCF - burning cash) (Net Debt 43.18b / FCF TTM -1.88b)
Total Stockholder Equity = -2.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 2.23b / Total Assets 168.24b)
RoE = -94.94% (negative equity) (Net Income TTM 2.23b / Total Stockholder Equity -2.35b)
RoCE = 12.49% (EBIT 5.41b / Capital Employed (Equity -2.35b + L.T.Debt 45.64b))
RoIC = 10.44% (NOPAT 5.34b / Invested Capital 51.18b)
WACC = 8.27% (E(181.50b)/V(235.60b) * Re(10.38%) + D(54.10b)/V(235.60b) * Rd(1.22%) * (1-Tc(0.01)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.22%
[DCF] Fair Price = unknown (Cash Flow -1.88b)
EPS Correlation: 21.39 | EPS CAGR: 29.55% | SUE: 4.0 | # QB: 1
Revenue Correlation: 61.43 | Revenue CAGR: 15.41% | SUE: 1.82 | # QB: 3
EPS next Quarter (2026-06-30): EPS=-0.08 | Chg7d=+0.000 | Chg30d=-0.212 | Revisions Net=-1 | Analysts=17
EPS current Year (2026-12-31): EPS=0.39 | Chg7d=+0.000 | Chg30d=-0.565 | Revisions Net=-14 | Growth EPS=-67.5% | Growth Revenue=+9.2%
EPS next Year (2027-12-31): EPS=4.70 | Chg7d=+0.000 | Chg30d=-0.377 | Revisions Net=-8 | Growth EPS=+1117.6% | Growth Revenue=+14.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.3% (Discount Rate 10.4% - Earnings Yield 1.1%)
[Growth] Growth Spread = -4.0% (Analyst 5.3% - Implied 9.3%)
P/E Forward = 163.9344
P/S = 2.0288
P/B = 33.3153
P/EG = 6.5305
Revenue TTM = 89.46b USD
EBIT TTM = 5.41b USD
EBITDA TTM = 7.36b USD
Long Term Debt = 45.64b USD (from longTermDebt, last quarter)
Short Term Debt = 8.46b USD (from shortTermDebt, last quarter)
Debt = 54.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.18b USD (from netDebt column, last quarter)
Enterprise Value = 224.68b USD (181.50b + Debt 54.10b - CCE 10.92b)
Interest Coverage Ratio = 1.95 (Ebit TTM 5.41b / Interest Expense TTM 2.77b)
EV/FCF = -119.7x (Enterprise Value 224.68b / FCF TTM -1.88b)
FCF Yield = -0.84% (FCF TTM -1.88b / Enterprise Value 224.68b)
FCF Margin = -2.10% (FCF TTM -1.88b / Revenue TTM 89.46b)
Net Margin = 2.50% (Net Income TTM 2.23b / Revenue TTM 89.46b)
Gross Margin = 4.83% ((Revenue TTM 89.46b - Cost of Revenue TTM 85.14b) / Revenue TTM)
Gross Margin QoQ = 7.57% (prev -10.21%)
Tobins Q-Ratio = 1.34 (Enterprise Value 224.68b / Total Assets 168.24b)
Interest Expense / Debt = 1.22% (Interest Expense 659.0m / Debt 54.10b)
Taxrate = 1.19% (99.0m / 8.32b)
NOPAT = 5.34b (EBIT 5.41b * (1 - 1.19%))
Current Ratio = 1.27 (Total Current Assets 137.59b / Total Current Liabilities 108.11b)
Debt / Equity = 9.92 (Debt 54.10b / totalStockholderEquity, last quarter 5.45b)
Debt / EBITDA = 5.87 (Net Debt 43.18b / EBITDA 7.36b)
Debt / FCF = -23.00 (negative FCF - burning cash) (Net Debt 43.18b / FCF TTM -1.88b)
Total Stockholder Equity = -2.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 2.23b / Total Assets 168.24b)
RoE = -94.94% (negative equity) (Net Income TTM 2.23b / Total Stockholder Equity -2.35b)
RoCE = 12.49% (EBIT 5.41b / Capital Employed (Equity -2.35b + L.T.Debt 45.64b))
RoIC = 10.44% (NOPAT 5.34b / Invested Capital 51.18b)
WACC = 8.27% (E(181.50b)/V(235.60b) * Re(10.38%) + D(54.10b)/V(235.60b) * Rd(1.22%) * (1-Tc(0.01)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.22%
[DCF] Fair Price = unknown (Cash Flow -1.88b)
EPS Correlation: 21.39 | EPS CAGR: 29.55% | SUE: 4.0 | # QB: 1
Revenue Correlation: 61.43 | Revenue CAGR: 15.41% | SUE: 1.82 | # QB: 3
EPS next Quarter (2026-06-30): EPS=-0.08 | Chg7d=+0.000 | Chg30d=-0.212 | Revisions Net=-1 | Analysts=17
EPS current Year (2026-12-31): EPS=0.39 | Chg7d=+0.000 | Chg30d=-0.565 | Revisions Net=-14 | Growth EPS=-67.5% | Growth Revenue=+9.2%
EPS next Year (2027-12-31): EPS=4.70 | Chg7d=+0.000 | Chg30d=-0.377 | Revisions Net=-8 | Growth EPS=+1117.6% | Growth Revenue=+14.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.3% (Discount Rate 10.4% - Earnings Yield 1.1%)
[Growth] Growth Spread = -4.0% (Analyst 5.3% - Implied 9.3%)